Jafron Biomedical Co.,Ltd. (SHE: 300529)

Jafron Biomedical Co.,Ltd. Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Oct 10, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Market Capitalization	23,800	17,755	24,741	42,653	54,196	30,077
Market Cap Growth	13.80%	-28.23%	-42.00%	-21.30%	80.19%	73.68%
Enterprise Value	22,719	16,803	23,822	41,394	52,930	29,001
Last Close Price	31.09	21.91	29.82	50.32	63.59	35.19
PE Ratio	34.85	39.84	26.63	33.78	58.88	48.88
PS Ratio	10.31	9.24	9.93	15.94	27.78	21.01
PB Ratio	7.92	5.63	6.89	12.61	19.13	13.86
P/FCF Ratio	25.69	26.52	60.65	59.91	90.27	82.90
P/OCF Ratio	17.14	19.37	27.99	34.14	56.60	51.55
EV/Sales Ratio	9.44	8.74	9.56	15.47	27.13	20.25
EV/EBITDA Ratio	24.90	29.40	23.92	30.15	52.81	45.72
EV/EBIT Ratio	28.15	34.79	25.71	31.27	54.82	47.97
EV/FCF Ratio	24.52	25.10	58.40	58.14	88.16	79.93
Debt / Equity Ratio	0.55	0.53	0.36	0.27	-	-
Debt / EBITDA Ratio	1.83	2.91	1.28	0.67	-	-
Debt / FCF Ratio	1.80	2.50	3.13	1.29	-	-
Asset Turnover	0.43	0.35	0.49	0.67	0.68	0.63
Inventory Turnover	1.41	1.05	1.61	2.54	2.70	2.57
Quick Ratio	2.83	3.49	3.91	7.21	5.44	5.49
Current Ratio	3.18	3.99	4.59	7.91	6.01	5.94
Return on Equity (ROE)	22.27%	12.63%	25.26%	38.47%	34.89%	29.22%
Return on Assets (ROA)	9.09%	5.51%	11.33%	20.61%	21.13%	16.62%
Return on Capital (ROIC)	10.39%	6.23%	12.63%	23.19%	24.12%	19.41%
Earnings Yield	2.87%	2.46%	3.60%	2.81%	1.61%	1.90%
FCF Yield	3.89%	3.77%	1.65%	1.67%	1.11%	1.21%
Dividend Yield	1.19%	1.83%	2.25%	1.79%	1.04%	1.35%
Payout Ratio	47.96%	128.70%	82.00%	44.37%	43.17%	43.97%
Buyback Yield / Dilution	0.32%	0.08%	1.12%	0.89%	-2.22%	-0.68%
Total Shareholder Return	1.51%	1.91%	3.36%	2.67%	-1.18%	0.66%

Source: S&P Capital IQ. Standard template. Financial Sources.